9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
It has been demonstrated that urethroplasty should be considered the gold standard treatment
 for urethral stricture disease as it yields higher long-term success rates than endoscopic
 treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data
 about these procedures exist, although most of the publications about urethroplasty are
 retrospective and involve a tremendous risk of bias. To address these issues, this study is
 designed to prospectively gain evidence about this matter in all patient subgroups facing a
 potential treatment with urethroplasty: native men, native women, transmen, transwomen and
 children.
Inclusion Criteria:

 -  Voluntarily signed written informed consent according to the rules of Good Clinical
 Practice (Declaration of Helsinki) and national regulations.

 -  Patient age ≥ 6 years.

 -  If a patient reaches the age of 18 years, he or she will have to provide a new
 voluntarily signed written informed consent. All patients reaching the age of 18 years
 will be contacted by the Principal Investigator or Subinvestigator to provide a new
 voluntarily signed written informed consent.

 Exclusion Criteria:

 - Absence of signed written informed consent and thus a patient unwilling to participate.